Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
February 25, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 25, 2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 25, 2021 S-3ASR

S-3ASR

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us